What are the current approved ways to use or apply Intrarosa during menopause treatment?

Intrarosa is approved for once-daily vaginal use at bedtime to treat moderate to severe vaginal dryness due to menopause, according to available prescribing guidelines.

Overview

Many women experience bothersome vaginal dryness during menopause, often due to decreased estrogen levels. Intrarosa is a non-estrogen treatment designed to support vaginal tissue health.

• It is specifically approved for use in postmenopausal women with vaginal symptoms like dryness and discomfort.
• Use is limited to local (vaginal) application and should follow a daily bedtime schedule.
• Patients are advised to speak with their healthcare provider before starting treatment.

This helps explain why understanding the approved usage method is essential for safety and results.

Detailed Information

How it works

Intrarosa may work by locally restoring levels of a hormone called DHEA (prasterone), which the body can convert into active sex hormones.

According to available data, Intrarosa helps promote the health of vaginal tissues without significantly raising systemic estrogen levels. This local effect may ease dryness and discomfort in the vaginal area.

Clinical applications

Intrarosa is approved for postmenopausal women with moderate to severe vaginal symptoms related to vulvovaginal atrophy, particularly dryness and pain during intercourse.

Use is focused on daily application to the vaginal area, making it a localized therapy option with minimal systemic hormone effects.

Safety and Effectiveness

Safety profile

According to the Israeli Ministry of Health prescribing document, common side effects may include vaginal discharge and slight spotting. These symptoms are generally mild and often resolve over time.

It is important to discuss any abnormal symptoms or persistent discomfort with a healthcare provider promptly.

FDA approval and indications

Intrarosa is FDA-approved specifically for treating moderate to severe vaginal dryness due to menopause. It is not indicated for other uses, such as systemic hormone replacement.

This approval is based on localized safety and effectiveness in postmenopausal patients seeking relief from vulvovaginal atrophy symptoms.

Access and Availability

How to obtain safely

IsraelPharm offers international access to Intrarosa at competitive prices for eligible patients with a valid prescription.

As with any hormone therapy, patients should consult their provider to ensure it is an appropriate treatment option for their symptoms and medical history.

Key Takeaways

• Intrarosa is applied once daily into the vagina using a prefilled applicator at bedtime.
• It is approved for treating moderate to severe vaginal dryness associated with menopause.
• The treatment acts locally and is not meant as systemic hormone therapy.
• Mild side effects like discharge may occur, especially early in treatment.
• A healthcare provider’s guidance is essential to ensure appropriate, safe use.

FAQ

Can I use Intrarosa every day?

Yes, Intrarosa is designed for nightly vaginal use. It should be applied once daily at bedtime unless your provider instructs otherwise.

How long does it take for Intrarosa to work?

Some women may notice symptom improvements within a few weeks. However, effects vary, and consistent nightly use is encouraged for best results.

Do I need a prescription to buy Intrarosa?

Yes, Intrarosa requires a valid prescription. Always consult your doctor before starting vaginal hormone-related treatments.

Is Intrarosa considered estrogen therapy?

No, while it is hormonally active, Intrarosa contains prasterone (DHEA), not estrogen. It acts locally and produces minimal systemic hormone changes.

How much does Intrarosa cost at IsraelPharm?

Prices can vary. Visit the IsraelPharm product page for current pricing and availability based on your location and prescription details.